STI
24
-7
FOXA
57
-2
LEN
46
-3
BK
68
-3
AVB
57
2
HIG
54
2
BXP
49
-3
EQIX
63
3
LB
9
-3
KLAC
57
3
C
60
-2
PYPL
62
2
AKAM
61
3
PPG
60
-4
EXPD
39
-11
PCG
56
-2
DFS
71
4
RHI
59
2
LEG
36
5
UNH
46
-6
STI
24
-7
FOXA
57
-2
LEN
46
-3
BK
68
-3
AVB
57
2
HIG
54
2
BXP
49
-3
EQIX
63
3
LB
9
-3
KLAC
57
3
C
60
-2
PYPL
62
2
AKAM
61
3
PPG
60
-4
EXPD
39
-11
PCG
56
-2
DFS
71
4
RHI
59
2
LEG
36
5
UNH
46
-6
Financhill
Back

Novonesis (Novozymes) B Stock Predictions

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
49

NVZMY
Novonesis (Novozymes) B

Last Price:
58.89
Seasonality Move:
2.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE

Novonesis (Novozymes) B Stock Forecast

  • Over the next 52 weeks, Novonesis (Novozymes) B has on average historically risen by 11% based on the past 18 years of stock performance.
  • Novonesis (Novozymes) B has risen higher in 12 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Novonesis (Novozymes) B Stock Undervalued?
    The current Novonesis (Novozymes) B [NVZMY] share price is $59.29. The Score for NVZMY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NVZMY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Novonesis (Novozymes) B Stock Go Up Next Year?

  • Over the next 52 weeks, Novonesis (Novozymes) B has on average historically risen by 11% based on the past 18 years of stock performance.

Novonesis (Novozymes) B Stock Rating

Sell
49
Novonesis (Novozymes) B (NVZMY) is a Sell

Is Novonesis (Novozymes) B overpriced?

  • Novonesis (Novozymes) B has risen higher in 12 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Novonesis (Novozymes) B Stock Price History

Is NVZMY stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVZMY is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Denmark
Industry:
Chemicals
Sector:
Materials
Type:
stock
Website:
novozymes.com

52-Week Data

52-Week High:
72.50
52-Week Low:
49.99

Prediction Charts

Market Cap:
27.53B
Price in USD:
59.29
Volume:
11.12K
Beta:
0.88

Technical Analysis

SMA50:
62.29
SMA100:
64.40
SMA200:
61.93
52-Wk Change:
13.11%

Stock Predictions

  • Is Novonesis (Novozymes) B stock public?
    Yes, Novonesis (Novozymes) B is a publicly traded company.
  • What is the Novonesis (Novozymes) B stock quote today?
    The Novonesis (Novozymes) B stock price is 59.29 USD today.
  • How to buy Novonesis (Novozymes) B stock online?
    You can buy Novonesis (Novozymes) B shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-21 57.55 57.46 57.82 57.29
Nov-22 59.23 59.38 59.80 59.22
Nov-25 59.79 59.86 60.16 59.69
Nov-26 58.71 58.48 58.75 58.20
Nov-27 58.65 58.60 58.85 58.48
Nov-29 57.76 58.75 58.75 57.75
Dec-2 58.24 59.02 59.15 58.09
Dec-3 58.56 58.14 59.08 57.91
Dec-4 58.22 58.41 58.70 58.22
Dec-5 58.71 58.74 59.12 58.61
Dec-6 58.77 58.89 59.07 58.47
Dec-9 58.98 58.48 59.05 58.48
Dec-10 59.08 58.63 59.09 58.50
Dec-11 58.86 59.29 59.50 58.86

Novonesis (Novozymes) B Earnings

Data Unavailable

Novonesis (Novozymes) B Forecast Revenue Growth

Data Unavailable

* Novonesis (Novozymes) B stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.